Beyond Proton Pump Inhibitors: Evaluating Treatment Strategies for Immune-Mediated Gastroenteritis from Cancer Immunotherapy.

Saved in:
Bibliographic Details
Title: Beyond Proton Pump Inhibitors: Evaluating Treatment Strategies for Immune-Mediated Gastroenteritis from Cancer Immunotherapy.
Authors: Cruz CC; Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, 1400 Pressler St, Houston, TX, 77030, USA., Santos MJMN; Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, 1400 Pressler St, Houston, TX, 77030, USA., Wali S; Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, 1400 Pressler St, Houston, TX, 77030, USA., Natha C; Department of Internal Medicine, The University of Texas Health Sciences Center, Houston, TX, USA., Mortan R; Department of Internal Medicine, The University of Texas Health Sciences Center, Houston, TX, USA., Ahuja R; Department of Internal Medicine, The University of Texas Health Sciences Center, Houston, TX, USA., Rong J; Department of Internal Medicine, The University of Texas Health Sciences Center, Houston, TX, USA., Gupta T; Department of Internal Medicine, The University of Texas Health Sciences Center, Houston, TX, USA., Lee IJ; Department of Internal Medicine, The University of Texas Health Sciences Center, Houston, TX, USA., Vemulapalli V; Department of Internal Medicine, The University of Texas Health Sciences Center, Houston, TX, USA., Ngo S; Department of Internal Medicine, The University of Texas Health Sciences Center, Houston, TX, USA., Takigawa K; Department of Internal Medicine, Baylor College of Medicine, Houston, TX, USA., Varatharajalu K; Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, 1400 Pressler St, Houston, TX, 77030, USA., Kim KC; Department Medicine, Stanford School of Medicine, San Jose, CA, USA., Bollin K; Department of Hematology and Oncology, Scripps Cancer Center, San Diego, CA, USA., Champiat S; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Shafi MA; Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, 1400 Pressler St, Houston, TX, 77030, USA., Thomas AS; Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, 1400 Pressler St, Houston, TX, 77030, USA., Wang Y; Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, 1400 Pressler St, Houston, TX, 77030, USA. ywang59@mdanderson.org.
Source: Targeted oncology [Target Oncol] 2026 Jan; Vol. 21 (1), pp. 103-115. Date of Electronic Publication: 2025 Dec 11.
Publication Type: Journal Article
Journal Info: Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1776-260X
DOI:10.1007/s11523-025-01190-0